Treg Specialization
Understanding How Regulatory T Cells Specialize to Control Inflammation
Regulatory T cells (Tregs) are a specialized group of immune cells essential for preventing excessive immune responses and maintaining balance in the body. Much like T helper cells, Tregs can adapt their behavior depending on the type of immune challenge they face. This ability to specialize helps them migrate to inflamed tissues and more effectively suppress harmful immune activity.
In type 1 immune responses, such as those triggered by viral infections, Tregs take on new characteristics. These include the expression of the transcription factor T-bet or the chemokine receptor CXCR3, which allow Tregs to better target and suppress overactive immune cells. Interestingly, these specialized Tregs can also use cytotoxic mechanisms, typically associated with killer T cells, to directly dampen inflammation. Disrupting this function in experimental models leads to worse disease outcomes, highlighting the importance of this suppressive strategy. We’ve also found that certain signals from the immune environment, such as the cytokine IL-12, play a crucial role in guiding Treg specialization. When this signaling is blocked, Tregs display reduced type 1 features and become less effective, which can alter the course of chronic disease.
Finally, our work extends to immune conditions driven by T helper 17 (Th17) immunity, which plays a role in infections with extracellular pathogens and autoimmune diseases like psoriasis. By analyzing immune cells at the single-cell level, we aim to uncover how Tregs change during Th17 inflammation, what drives these changes, and how this knowledge can be applied to human disease.
Together, these studies shed light on how Tregs fine-tune their activity to control inflammation, and how this flexibility could be harnessed to improve treatments for infections, autoimmunity, and other immune-related disorders.
